全球牲畜疫苗市场规模，依疫苗类型、目标动物种类、给药方式、最终用户、区域范围及预测

牲畜疫苗的市场规模及预测

2024 年牲畜疫苗市场规模价值 95 亿美元，预计到 2032 年将达到 166.3 亿美元，2026 年至 2032 年的复合年增长率为 7.25%。

推动全球牲畜疫苗市场的因素

牲畜疫苗的市场驱动力可能受到多种因素的影响，其中包括：

动物性蛋白质需求不断增长：随着世界人口的增长，对肉类和乳製品的需求也随之增加。这增加了对健康牲畜的需求，也增加了对疫苗接种的需求，以防止可能降低牲畜生产力的疾病。

牲畜疾病传播：口蹄疫、禽流感、猪隻繁殖与呼吸综合症（PRRS）等疾病会为畜牧业带来巨大的经济损失。疫苗接种在预防和控制这些疾病方面发挥着至关重要的作用，因此对牲畜疫苗的需求不断增加。

政府措施和立法：为了遏制动物疾病的传播，政府和监管机构经常颁布计画和立法，包括疫苗宣传活动，从而产生对牲畜疫苗的持续需求。

技术发展：生物技术和疫苗研究的进步带来了更优质、更安全的疫苗接种。这些发展正在激发市场创造力，促进市场扩张。

增加对动物健康的投资：由于对支持动物保健的基础设施的投资增加以及对动物健康和福利重要性的认识不断提高，兽医疫苗市场正在扩大。

贸易全球化：随着贸易的扩大，疾病的国际传播可能性也随之增加。因此，疫苗宣传活动对于阻止疾病传入和传播到新地区变得更加重要。

通用感染疾病是指可从动物传播给人类的感染疾病，且正变得越来越普遍。兽医疫苗的需求源于这样一个事实：为动物接种疫苗不仅可以保护它们免受某些疾病的侵害，还能降低它们传播给人类的可能性。

转向预防性医疗保健：畜牧业的一个趋势是，农民越来越注重疾病预防而不是治疗，这将促进疫苗接种计划的实施，并增加农业动物疫苗的市场。

集约化养殖模式日益普及：像集中饲养模式（CAFO）这样的集约化养殖模式，由于牲畜饲养空间狭小，增加了疾病爆发的风险。在这种环境下，疫苗接种对于阻止疾病传播至关重要，这增加了对牲畜疫苗的需求。

限制全球牲畜疫苗市场的因素

牲畜疫苗市场可能面临多种限制和挑战，其中包括：

监管挑战：监管挑战：疫苗审批程序漫长而严格，这可能会延迟市场采用和成长。

开发成本高：开发牲畜疫苗相关的研发成本会限制市场参与企业并推高疫苗价格。

知识有限：在某些地区，市场成长可能会受到农民的阻碍，因为他们不了解给牲畜接种疫苗的好处，或对其有效性持怀疑态度。

基础设施挑战：疫苗分发、管理和储存基础设施不足可能会阻碍发展，尤其是在新兴国家。

细分市场：大量小型生产者可能导致牲畜疫苗市场细分，从而给价格带来上行压力并限制创新。

疾病管制技术：有效的疾病控制技术，例如使用抗生素和生物安全措施，可以大幅减少某些农业经营中对疫苗接种的需求。

来自传统药物的竞争：在某些市场，疫苗可能面临来自预防和治疗疾病的传统手段（如抗生素和草药）的竞争。

经济因素：经济因素：经济衰退和商品价格波动可能会影响农民购买疫苗和其他预防措施的能力。

对过度使用的担忧：过度使用疫苗会导致对疫苗有抗药性的疾病菌株，并对牲畜健康产生不利影响。

抵制变革：农民和农业社区可能会抵制采用新技术和新做法，例如疫苗接种，这可能会阻碍市场扩张。

目录

第一章全球牲畜疫苗市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球牲畜疫苗市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球牲畜疫苗市场（依疫苗类型）

• 活病毒疫苗
• 灭活疫苗
• 次单位疫苗
• DNA疫苗

6. 全球兽用疫苗市场（依动物种类）

• 牛
• 猪
• 家禽
• 绵羊和山羊

7. 全球牲畜疫苗市场（依给药方式）

• 注射疫苗
• 口服疫苗
• 鼻用疫苗

8. 全球牲畜疫苗市场（依最终用户）

• 兽医医院和诊所
• 畜牧生产者
• 兽医诊断实验室
• 动物保健公司

9. 全球牲畜疫苗市场（按地区）

• 概述
• 北美洲
  • 美国
• 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第十章全球兽用疫苗市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十一章 公司简介

• Boehringer Ingelheim
• Merck
• Zoetis
• WINSUN
• Ringpu Biology
• Ceva
• CAHIC
• HVRI
• Bio-Labs
• Yebio

第十二章 附录

• 相关调查

Farm Animal Vaccine Market Size And Forecast

Farm Animal Vaccine Market size was valued at USD 9.5 USD Billion in 2024 and is projected to reach USD 16.63 USD Billion by 2032, growing at a CAGR of 7.25% during the forecast period 2026-2032.

Global Farm Animal Vaccine Market Drivers

The market drivers for the Farm Animal Vaccine Market can be influenced by various factors. These may include:

Growing Need for Animal Protein: The demand for meat and dairy products rises in tandem with the growth of the world's population. Because of this, there is a greater requirement for healthy farm animals, which raises the need for vaccinations to stave off illnesses that could lower livestock productivity.

Animal illness prevalence: The cattle business can suffer large financial losses as a result of diseases including foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS). The need for vaccines for agricultural animals is fueled by the critical role immunizations play in both preventing and controlling these diseases.

Government Initiatives and laws: To stop the spread of animal diseases, governments and regulatory agencies frequently put programs and laws into place. This includes immunization campaigns, which generate a consistent need for vaccines for farm animals.

Technological developments: Better and safer vaccinations for farm animals have been made possible by developments in biotechnology and vaccine research. These developments stimulate the market's creativity and aid in its expansion.

Increasing Investments in Animal Health: The market for farm animal vaccines is expanding as a result of rising investments in the infrastructure supporting animal healthcare as well as growing awareness of the significance of animal health and welfare.

Trade Globalization: As trade grows, there is a greater chance that diseases will spread internationally. As a result, immunization campaigns are more important to stop the introduction and spread of illnesses to new areas.

Zoonotic diseases are infections that can spread from animals to people and are becoming more common. The need for farm animal vaccines is fueled by the fact that immunizing animals against certain illnesses not only protects them but also lowers the possibility of human infection.

Transition to Preventive Healthcare: Farmers are putting more of an emphasis on preventing illnesses than treating them as a result of a growing tendency in animal husbandry. This promotes vaccination programs' uptake and expands the market for vaccines intended for agricultural animals.

Growing Adoption of Intensive Farming Practices: Because animals are kept in close quarters, intensive farming methods-like concentrated animal feeding operations (CAFOs)-increase the danger of disease outbreaks. Because vaccinations are crucial in stopping the spread of disease in these kinds of settings, there is an increased need for farm animal vaccines.

Global Farm Animal Vaccine Market Restraints

Several factors can act as restraints or challenges for the Farm Animal Vaccine Market. These may include:

Regulatory Difficulties: The lengthy and rigorous regulatory licensing procedures for vaccines might cause delays in the introduction or growth of the market.

High Development expenditures: Research and development expenditures associated with developing vaccines for farm animals might restrict market participants and drive up vaccine pricing.

Limited Knowledge: The growth of the market may be hampered in some areas by farmers who are unaware of the advantages of vaccinations for their animals or who have doubts about their effectiveness.

Infrastructure Challenges: Inadequate infrastructure for the distribution, administration, and storage of vaccines might obstruct market expansion in some areas, particularly in developing nations.

Fragmented Market: Due to the large number of small-scale producers, the market for farm animal vaccines may be fragmented, which could put pressure on prices and restrict innovation.

Disease Control techniques: In certain farming operations, the apparent need for vaccinations may be lessened by effective disease control techniques such the use of antibiotics and biosecurity measures.

Competition from Traditional Medicines: In certain markets, vaccines may face competition from traditional means of illness prevention and treatment, such as antibiotics or herbal medicines.

Economic Factors: Farmers' capacity to spend in vaccines and other preventive measures may be impacted by downturns in the economy or changes in commodity prices.

Concerns regarding Overuse: There may be worries that using vaccines excessively could result in the emergence of disease strains resistant to vaccinations or have a negative impact on the health of animals.

Resistance to Change: Some farmers or farming communities may be resistant to implementing new technologies or practices, such as vaccinations, which could impede the expansion of the market.

Global Farm Animal Vaccine Market Segmentation Analysis

The Global Farm Animal Vaccine Market is Segmented on the basis of Type of Vaccine, Target Animal Species, Administration Method, End-User, and Geography.

Farm Animal Vaccine Market, By Type of Vaccine

• Live Attenuated Vaccines: Vaccines containing weakened forms of the pathogen that stimulate an immune response in animals without causing disease, providing long-lasting immunity with a single dose.
• Inactivated Vaccines: Vaccines containing killed or inactivated pathogens, which require multiple doses or booster shots to induce immunity but are safer for use in pregnant animals and young animals with developing immune systems.
• Subunit Vaccines: Vaccines composed of specific antigens or proteins from the pathogen, offering targeted immune responses with reduced risk of adverse reactions compared to whole-cell vaccines.
• DNA Vaccines: Vaccines that deliver genetic material encoding antigenic proteins into animal cells, stimulating both humoral and cellular immune responses for long-term protection against pathogens.

Farm Animal Vaccine Market, By Target Animal Species

• Cattle: Vaccines developed specifically for cattle to prevent diseases such as bovine respiratory disease (BRD), bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), and clostridial infections.
• Pigs: Vaccines designed for pigs to protect against diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, porcine circovirus-associated diseases (PCVAD), and classical swine fever.
• Poultry: Vaccines formulated for poultry species including chickens, turkeys, and ducks to prevent diseases such as Newcastle disease, infectious bronchitis, avian influenza, Marek's disease, and infectious bursal disease.
• Sheep and Goats: Vaccines tailored for sheep and goats to control diseases such as foot-and-mouth disease (FMD), enterotoxemia, clostridial infections, and contagious ecthyma (orf).

Farm Animal Vaccine Market, By Administration Method

• Injectable Vaccines: Vaccines administered through injection into muscle tissue or under the skin, providing targeted delivery and reliable immune responses.
• Oral Vaccines: Vaccines administered orally through feed or drinking water, offering ease of administration and potential for mass vaccination of large animal populations.
• Intranasal Vaccines: Vaccines delivered through the nasal passages, stimulating mucosal immunity and providing protection against respiratory pathogens in farm animals.

Farm Animal Vaccine Market, By End-User

• Veterinary Hospitals and Clinics: Facilities providing veterinary services and healthcare to farm animals, including vaccination programs, preventive care, and treatment of infectious diseases.
• Livestock Producers: Farmers, ranchers, and livestock producers responsible for managing the health and well-being of farm animals, including implementing vaccination protocols and disease prevention strategies.
• Veterinary Diagnostic Laboratories: Laboratories conducting diagnostic tests, serological assays, and vaccine efficacy studies to monitor disease prevalence, assess vaccine effectiveness, and guide vaccination strategies.
• Animal Health Companies: Manufacturers and suppliers of farm animal vaccines, veterinary pharmaceuticals, and biological products, offering a range of vaccine formulations and solutions for disease prevention and control.

Farm Animal Vaccine Market, By Geographic

• North America: Market dynamics and trends specific to the farm animal vaccine industry in North American regions, including the United States, Canada, and Mexico.
• Europe: Market factors and regulatory influences shaping the farm animal vaccine market across European countries such as the UK, Germany, France, and Italy.
• Asia Pacific: Growth opportunities and market expansion strategies relevant to farm animal vaccines in countries like China, India, Japan, and Australia.
• Latin America: Market trends and consumer preferences impacting the farm animal vaccine market in Latin American regions like Brazil, Argentina, and Chile.
• Middle East and Africa: Factors driving demand for farm animal vaccines in regions like the Middle East and Africa, including increasing livestock production, disease outbreaks, and government initiatives for animal health.

Key Players

• The major players in the Farm Animal Vaccine Market are:
• Elanco
• Virbac
• Vetoquinol S.A.

4Hester Biosciences Limited

• Phibro Animal Health Corporation
• HIPRA

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FARM ANIMAL VACCINE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FARM ANIMAL VACCINE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL FARM ANIMAL VACCINE MARKET, BY TYPE OF VACCINE

• 5.1 Live Attenuated Vaccines
• 5.2 Inactivated Vaccines
• 5.3 Subunit Vaccines
• 5.4 DNA Vaccines

6 GLOBAL FARM ANIMAL VACCINE MARKET, BY TARGET ANIMAL SPECIES

• 6.1 Cattle
• 6.2 Pigs
• 6.3 Poultry
• 6.4 Sheep and Goats

7 GLOBAL FARM ANIMAL VACCINE MARKET, BY ADMINISTRATION METHOD

• 7.1 Injectable Vaccines
• 7.2 Oral Vaccines
• 7.3 Intranasal Vaccines

8 GLOBAL FARM ANIMAL VACCINE MARKET, BY END-USER

• 8.1 Veterinary Hospitals and Clinics
• 8.2 Livestock Producers
• 8.3 Veterinary Diagnostic Laboratories
• 8.4 Animal Health Companies

9 GLOBAL FARM ANIMAL VACCINE MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
• 92.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East And Africa

10 GLOBAL FARM ANIMAL VACCINE MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 Boehringer Ingelheim
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Merck
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Zoetis
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 WINSUN
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Ringpu Biology
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Ceva
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.11 CAHIC
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.8 HVRI
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.11 Bio-Labs
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.10 Yebio
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments

12 Appendix

• 10.1 Related Research